Cryptosporidium: Novartis and the Bill & Melinda Gates Foundation form alliance to develop drug candidate
by Press Release from Outbreak News Today on (#3G83H)
Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance development of Novartis' drug candidate KDU731 for the treatment of cryptosporidiosis. Diarrheal diseases are one of the leading causes of childhood mortality globally, resulting in approximately 525,000 deaths each year and cryptosporidiosis is the second leading cause of infectious diarrhea in ["]
The post Cryptosporidium: Novartis and the Bill & Melinda Gates Foundation form alliance to develop drug candidate appeared first on Outbreak News Today.